In vitro identification of human cytochrome P450 isoforms involved in the metabolism of Geissoschizine methyl ether, an active component of the traditional Japanese medicine Yokukansan

References

• Dalvie D, Obach RS, Kang P, et al. (2009). Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites. Chem Res Toxicol 22:357–68
   PubMed Web of Science ®Google Scholar
• Dennison JB, Kulanthaivel P, Barbuch RJ, et al. (2006). Selective metabolism of vincristine in vitro by CYP3A5. Drug Metab Dispos 34:1317–27
   PubMed Web of Science ®Google Scholar
• Eiselt R, Domanski TL, Zibat A, et al. (2001). Identification and functional characterization of eight CYP3A4 protein variants. Pharmacogenetics 11:447–58
   PubMedGoogle Scholar
• Evans WE, Relling MV. (1999). Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286:487–91
   PubMed Web of Science ®Google Scholar
• Gai Y, Chen H, Liu W, et al. (2014). The metabolism of YiGan San and subsequent pharmacokinetic evaluation of four metabolites in rat based on liquid chromatography with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 972:22--8
   Google Scholar
• Guengerich FP. (1999). Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39:1–17
   PubMed Web of Science ®Google Scholar
• Hsu A, Granneman GR, Cao G, et al. (1998). Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir. Clin Pharmacol Ther 63:453–64
   PubMed Web of Science ®Google Scholar
• Iwasaki K, Kosaka K, Mori H, et al. (2012). Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine. Psychogeriatrics 12:235–41
   PubMed Web of Science ®Google Scholar
• Kawakami Z, Kanno H, Ikarashi Y, Kase Y. (2011). Yokukansan, a kampo medicine, protects against glutamate cytotoxicity due to oxidative stress in PC12 cells. J Ethnopharmacol 134:74–81
   PubMed Web of Science ®Google Scholar
• Kivisto KT, Kantola T, Neuvonen PJ. (1998). Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin. Br J Clin Pharmacol 46:49–53
   PubMed Web of Science ®Google Scholar
• Kuehl P, Zhang J, Lin Y, et al. (2001). Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27:383–91
   PubMed Web of Science ®Google Scholar
• Kushida H, Fukutake M, Tabuchi M, et al. (2013). Simultaneous quantitative analyses of indole and oxindole alkaloids of Uncaria Hook in rat plasma and brain after oral administration of the traditional Japanese medicine Yokukansan using high-performance liquid chromatography with tandem mass spectrometry. Biomed Chromatogr 27:1647–56
   PubMed Web of Science ®Google Scholar
• Le Corre P, Parmer RJ, Kailasam MT, et al. (2004). Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: bimodal, epistatic influence of cytochrome P450-mediated drug metabolism. Clin Pharmacol Ther 76:139–53
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Kishi T, Shibayama H, Iwata N. (2013). Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials. Hum Psychopharmacol 28:80–6
   PubMed Web of Science ®Google Scholar
• Mizukami K, Asada T, Kinoshita T, et al. (2009). A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int J Neuropsychopharmacol 12:191–9
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Banba K, Hata K, et al. (2006). Metabolites of hirsuteine and hirsutine, the major indole alkaloids of Uncaria rhynchophylla, in rats. Biol Pharm Bull 29:1671–7
   PubMed Web of Science ®Google Scholar
• Nishi A, Yamaguchi T, Sekiguchi K, et al. (2012). Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin (1)A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan. Neuroscience 207:124–36
   PubMed Web of Science ®Google Scholar
• Preissner S, Kroll K, Dunkel M, et al. (2010). SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res 38:D237–43
   PubMed Web of Science ®Google Scholar
• Seigler DS. (1998). Plant secondary metabolism. Boston: Kluwer Academic
   Google Scholar
• Shimada T, Yamazaki H, Mimura M, et al. (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–23
   PubMed Web of Science ®Google Scholar
• Soars MG, Gelboin HV, Krausz KW, Riley RJ. (2003). A comparison of relative abundance, activity factor and inhibitory monoclonal antibody approaches in the characterization of human CYP enzymology. Br J Clin Pharmacol 55:175–81
   PubMed Web of Science ®Google Scholar
• Ueda T, Ugawa S, Ishida Y, Shimada S. (2011). Geissoschizine methyl ether has third-generation antipsychotic-like actions at the dopamine and serotonin receptors. Eur J Pharmacol 671:79–86
   PubMed Web of Science ®Google Scholar
• Ueki T, Nishi A, Imamura S, et al. (2013). Effects of geissoschizine methyl ether, an indole alkaloid in Uncaria hook, a constituent of yokukansan, on human recombinant serotonin 7 receptor. Cell Mol Neurobiol 33:129–35
   PubMed Web of Science ®Google Scholar
• Whyatt RM, Garte SJ, Cosma G, et al. (1995). CYP1A1 messenger RNA levels in placental tissue as a biomarker of environmental exposure. Cancer Epidemiol Biomarkers Prev 4:147–53
   PubMed Web of Science ®Google Scholar